233 related articles for article (PubMed ID: 12654827)
1. Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune response.
An CL; Gigliotti F; Harmsen AG
Infect Immun; 2003 Apr; 71(4):2065-70. PubMed ID: 12654827
[TBL] [Abstract][Full Text] [Related]
2. Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice.
Gigliotti F; Harmsen AG; Wright TW
Infect Immun; 2003 Jul; 71(7):3852-6. PubMed ID: 12819069
[TBL] [Abstract][Full Text] [Related]
3. Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts.
Dumoulin A; Mazars E; Seguy N; Gargallo-Viola D; Vargas S; Cailliez JC; Aliouat EM; Wakefield AE; Dei-Cas E
Eur J Clin Microbiol Infect Dis; 2000 Sep; 19(9):671-8. PubMed ID: 11057500
[TBL] [Abstract][Full Text] [Related]
4. [Susceptibility and immune responses to Pneumocystis carinii infection in different strains of mice by contagious transmission].
An CL; Su XP; Harmsen AG
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(4):220-2. PubMed ID: 12568024
[TBL] [Abstract][Full Text] [Related]
5. Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure.
Linke MJ; Ashbaugh AD; Demland JA; Walzer PD
Respir Res; 2009 Feb; 10(1):10. PubMed ID: 19228388
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model.
Shellito JE; Kolls JK; Olariu R; Beck JM
J Infect Dis; 1996 Feb; 173(2):432-9. PubMed ID: 8568306
[TBL] [Abstract][Full Text] [Related]
7. Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation.
Empey KM; Hollifield M; Schuer K; Gigliotti F; Garvy BA
Infect Immun; 2004 Nov; 72(11):6211-20. PubMed ID: 15501746
[TBL] [Abstract][Full Text] [Related]
8. Exogenous heat-killed Escherichia coli improves alveolar macrophage activity and reduces Pneumocystis carinii lung burden in infant mice.
Empey KM; Hollifield M; Garvy BA
Infect Immun; 2007 Jul; 75(7):3382-93. PubMed ID: 17485459
[TBL] [Abstract][Full Text] [Related]
9. Immunocompetent hosts as a reservoir of pneumocystis organisms: histological and rt-PCR data demonstrate active replication.
Chabé M; Dei-Cas E; Creusy C; Fleurisse L; Respaldiza N; Camus D; Durand-Joly I
Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):89-97. PubMed ID: 14712369
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis carinii f. sp. hominis is not infectious for SCID mice.
Durand-Joly I; Aliouat el M; Recourt C; Guyot K; François N; Wauquier M; Camus D; Dei-Cas E
J Clin Microbiol; 2002 May; 40(5):1862-5. PubMed ID: 11980979
[TBL] [Abstract][Full Text] [Related]
11. Quantitative real-time polymerase chain-reaction assay allows characterization of pneumocystis infection in immunocompetent mice.
Vestereng VH; Bishop LR; Hernandez B; Kutty G; Larsen HH; Kovacs JA
J Infect Dis; 2004 Apr; 189(8):1540-4. PubMed ID: 15073693
[TBL] [Abstract][Full Text] [Related]
12. Evidence of airborne excretion of Pneumocystis carinii during infection in immunocompetent rats. Lung involvement and antibody response.
Menotti J; Emmanuel A; Bouchekouk C; Chabe M; Choukri F; Pottier M; Sarfati C; Aliouat el M; Derouin F
PLoS One; 2013; 8(4):e62155. PubMed ID: 23626781
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection.
Linke MJ; Harris CE; Korfhagen TR; McCormack FX; Ashbaugh AD; Steele P; Whitsett JA; Walzer PD
J Infect Dis; 2001 Mar; 183(6):943-52. PubMed ID: 11237812
[TBL] [Abstract][Full Text] [Related]
14. Latency is not an inevitable outcome of infection with Pneumocystis carinii.
Chen W; Gigliotti F; Harmsen AG
Infect Immun; 1993 Dec; 61(12):5406-9. PubMed ID: 7901169
[TBL] [Abstract][Full Text] [Related]
15. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice.
Harmsen AG; Chen W; Gigliotti F
Infect Immun; 1995 Jul; 63(7):2391-5. PubMed ID: 7790048
[TBL] [Abstract][Full Text] [Related]
16. Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection.
Chen W; Havell EA; Harmsen AG
Infect Immun; 1992 Apr; 60(4):1279-84. PubMed ID: 1548057
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.
Miller RF; Ambrose HE; Wakefield AE
J Clin Microbiol; 2001 Nov; 39(11):3877-82. PubMed ID: 11682501
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis carinii enhances soluble mannose receptor production by macrophages.
Fraser IP; Takahashi K; Koziel H; Fardin B; Harmsen A; Ezekowitz RA
Microbes Infect; 2000 Sep; 2(11):1305-10. PubMed ID: 11018446
[TBL] [Abstract][Full Text] [Related]
19. Activity of Hoechst 33258 against Pneumocystis carinii f. sp. muris, Candida albicans, and Candida dubliniensis.
Disney MD; Stephenson R; Wright TW; Haidaris CG; Turner DH; Gigliotti F
Antimicrob Agents Chemother; 2005 Apr; 49(4):1326-30. PubMed ID: 15793106
[TBL] [Abstract][Full Text] [Related]
20. Neonatal T cells in an adult lung environment are competent to resolve Pneumocystis carinii pneumonia.
Qureshi MH; Garvy BA
J Immunol; 2001 May; 166(9):5704-11. PubMed ID: 11313412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
